PAX8-PPAR gamma 1 fusion in oncogene human thyroid carcinoma

Citation
Tg. Kroll et al., PAX8-PPAR gamma 1 fusion in oncogene human thyroid carcinoma, SCIENCE, 289(5483), 2000, pp. 1357-1360
Citations number
49
Categorie Soggetti
Multidisciplinary,Multidisciplinary,Multidisciplinary
Journal title
SCIENCE
ISSN journal
00368075 → ACNP
Volume
289
Issue
5483
Year of publication
2000
Pages
1357 - 1360
Database
ISI
SICI code
0036-8075(20000825)289:5483<1357:PG1FIO>2.0.ZU;2-M
Abstract
Chromosomal translocations that encode fusion oncoproteins have been observ ed consistently in leukemias/lymphomas and sarcomas but not in carcinomas, the most common human cancers. Here, we report that t(2;3)(q13;p25), a tran slocation identified in a subset of human thyroid follicular carcinomas, re sults in fusion of the DNA binding domains of the thyroid transcription fac tor PAX8 to domains A to F of the peroxisome proliferator-activated recepto r (PPAR) gamma 1. PAX8-PPAR gamma 1 mRNA and protein were detected in 5 of 8 thyroid follicular carcinomas but not in 20 follicular adenomas, 10 papil lary carcinomas, or 10 multinodular hyperplasias. PAX8-PPAR gamma 1 inhibit ed thiazolidinedione-induced transactivation by PPAR gamma 1 in a dominant negative manner. The experiments demonstrate an oncogenic role for PPAR gam ma and suggest that PAX8-PPAR gamma 1 may be useful in the diagnosis and tr eatment of thyroid carcinoma.